These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 7000236)

  • 1. Secondary prevention of myocardial infarction--the present state of the ART.
    Mitchell JR
    Br Med J; 1980 May; 280(6223):1128-30. PubMed ID: 7000236
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiplatelet drugs in the secondary prevention of myocardial infarction. One view of the present position.
    McNicol GP
    Lancet; 1980 Oct; 2(8197):736-8. PubMed ID: 6106840
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of drugs of platelets and complications of vascular disease.
    Mustard JF; Packham MA; Kinlough-Rathbone RL
    Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prevention of myocardial infarction by chemotherapy].
    Toshima H; Adachi K
    Nihon Rinsho; 1982; 40(11):2465-70. PubMed ID: 6130172
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention: a difficult link.
    de Gaetano G; Cerletti C; Bertelè V
    Lancet; 1982 Oct; 2(8305):974-7. PubMed ID: 6127469
    [No Abstract]   [Full Text] [Related]  

  • 6. Myocardial infarction.
    Prentice CR
    Clin Haematol; 1981 Jun; 10(2):521-41. PubMed ID: 7032787
    [No Abstract]   [Full Text] [Related]  

  • 7. Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction.
    Hirsh J
    Arch Intern Med; 1981 Feb; 141(3 Spec No):311-5. PubMed ID: 7008733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiplatelet drugs after acute myocardial infarction.
    Mannucci PM
    Ric Clin Lab; 1984; 14(1):1-7. PubMed ID: 6729352
    [No Abstract]   [Full Text] [Related]  

  • 9. Anticoagulants and platelet-active agents in the secondary prevention of coronary artery disease.
    Van Aken WG
    Adv Cardiol; 1982; 31():98-101. PubMed ID: 6758512
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical trials in thrombosis: secondary prevention of myocardial infarction.
    Klimt CR; Doub PH; Doub NH
    Thromb Haemost; 1976 Feb; 35(1):49-56. PubMed ID: 785688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
    Cairns JA
    Cardiovasc Clin; 1987; 18(1):231-46. PubMed ID: 3300983
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood platelets and myocardial infarction].
    Musiał J; Dworski R; Szczeklik A
    Pol Tyg Lek; 1984 Dec; 39(50):1665-8. PubMed ID: 6396594
    [No Abstract]   [Full Text] [Related]  

  • 13. [Platelet aggregation inhibitors in the prevention of myocardial infarction: the results of prospective studies].
    Shalaev SV
    Kardiologiia; 1989 Sep; 29(9):116-20. PubMed ID: 2687554
    [No Abstract]   [Full Text] [Related]  

  • 14. [Secondary prevention of ischemic cardiopathy with anti-platelet aggregates in the post-infarct patient. Review].
    Verdecchia P
    G Ital Cardiol; 1982; 12(8):598-603. PubMed ID: 6762978
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiplatelet agents in prevention of myocardial infarction.
    Kshirsagar NA
    Indian Heart J; 1983; 35(1):60-6. PubMed ID: 6303947
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
    Castaldi PA
    Aust N Z J Med; 1981 Dec; 11(6):673-7. PubMed ID: 7036973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials evaluating platelet-modifying drugs in patients with atherosclerotic cardiovascular disease and thrombosis.
    Harker LA
    Circulation; 1986 Feb; 73(2):206-23. PubMed ID: 3510760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Present situation of therapy with platelet aggregation inhibitors].
    Poliwoda H
    Acta Med Austriaca Suppl; 1982; 25():55-61. PubMed ID: 6958157
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antiplatelet drugs (author's transl)].
    Dechavanne M; Follea G; Trzeciak MC
    Anesth Analg (Paris); 1979; 36(7-8):283-7. PubMed ID: 525834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E.P.S.I.M., the French oral anticoagulant--aspirin trial in post-myocardial infarction patients: design, organization and quality control procedures.
    Boissel JP; Leizorovicz A; Schbath J; Destors JM; Gillet J
    Scand J Haematol Suppl; 1981; 38():47-72. PubMed ID: 7038857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.